Retatrutide 10mg Overview

Retatrutide is a synthetic research peptide designed as a triple agonist of the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This unique receptor activity profile makes Retatrutide a valuable compound in preclinical studies exploring metabolic regulation, weight management pathways, and glucose homeostasis.

Product Details

• Form: Lyophilized (freeze-dried) powder

• Strength: 10 mg per vial

• Molecular Formula: C₂₁₉H₃₄₆N₆₀O₆₆

• Molecular Weight: ~ 4825 g/mol

• CAS Number: 2381089-83-2

• Storage: Store in a cool, dry place; refrigerate (2–8°C) after reconstitution

Research Highlights

• Triple Agonist Mechanism: Investigated for simultaneous activation of GLP-1, GIP, and glucagon receptors in experimental models.

• Metabolic Pathway Studies: Explored for its potential role in regulating glucose metabolism, appetite signaling, and energy expenditure.

• Preclinical Obesity Models: Used in laboratory settings to better understand mechanisms of weight regulation and metabolic disorders.

Usage and Safety Information

This compound is intended for laboratory research use only. It is not approved for human or veterinary use. Proper laboratory safety protocols should be followed when handling Retatrutide.

Important Notices

• Product is sold strictly for scientific research purposes.

• Supplied as a lyophilized powder in a sealed sterile vial.

• Quantity on label reflects total peptide content per vial (10 mg).

• Requires reconstitution with bacteriostatic water prior to use in laboratory experiments.

• Vial appearance, label, seal, and cap colors may vary from product photos.